GENE ONLINE|News &
Opinion
Blog

Intellia Therapeutics
Trials & Approvals CRISPR
Intellia’s CRISPR Drug Claims FDA Orphan Drug Designation to Treat ATTR Amyloidosis
2021-10-22
Trials & Approvals Gene Editing
A New Era Begins! Intellia Reports First Clinical Proof for Direct CRISPR Genome Editing in Humans
2021-06-27
Startups
Blackstone Pumps $250 Million in CAR-T Startup, Betting on Intellia’s and Cellex’s Technologies
2021-06-23
Ranking & Reports Gene Therapy
10 Top Gene Therapy Companies in 2021
2021-03-26
Trials & Approvals CRISPR
Intellia Trials CRISPR Drug as Permanent Cure to Fatal Hereditary Disease
2020-10-21
Hemophilia B
CSL Behring to Tackle Hemophilia B Using UniQure’s Gene Therapy Program
2020-06-28
Trials & Approvals
ASGCT20: Intellia Presents Data on Two of its CRISPR-Based Novel Therapeutic Candidates
2020-05-16
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top